Efficient and effective identification of cancer neoantigens from tumor only RNA-seq
NAR Genomics and Bioinformatics · 2025
DOI: 10.1093/nargab/lqaf026 ↗Kurz gefasst
Fachartikel in der Zeitschrift NAR Genomics and Bioinformatics, 2025. Verfasst von Danilo Tatoni und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Informatics and Telematics (IIT), National Research Council (CNR), 56124 Pisa, Italy. Hauptthemen laut MEDLINE: Neoplasms, Antigens, Neoplasm, RNA-Seq. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: European Union-Next Generation EU, Tuscany Health Ecosystem, Advanced ERC.
Abstract (Originalsprache)
The growing accessibility of sequencing experiments has significantly accelerated the development of personalized immunotherapies based on the identification of cancer neoantigens. However, predicting neoantigens involves lengthy and inefficient protocols, which require simultaneous analysis of sequencing data from paired tumor/normal exomes and tumor transcriptome, often resulting in a low success rate. To date, the feasibility of adopting a more efficient strategy has not been fully evaluated. To this end, we developed ENEO, a computational approach to detect cancer neoantigens using solely the tumor RNA-seq data while addressing the lack of matched control through a Bayesian probabilistic model. ENEO was assessed on the TESLA benchmark dataset, reporting efficient identification of DNA-alterations derived neoantigens and compelling results against state-of-art exome-based methods. We further validated the method on two independent cohorts, encompassing different tumor types and experimental procedures. Our work demonstrates that a tumor-only RNA-based approach, such as the one implemented in ENEO, maintains accuracy in identifying mutated peptides resulting from expressed genomic alterations while also broadening the pool of potential neoantigens with RNA-specific mutations in a faster and cost-effective way. ENEO is freely available at the URL: https://github.com/ctglab/ENEO
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Informatics and Telematics (IIT), National Research Council (CNR), 56124 Pisa, Italy.
- Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.
- Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, 38131 Trento, Italy.
- Institute of Clinical Physiology (IFC), National Research Council (CNR) and Core Research Laboratory, Istituto per lo Studio, la prevenzione e la Rete Oncologica (ISPRO), 53100 Siena, Italy.
ORCID-Profile: Romina D'Aurizio
Förderung
- European Union-Next Generation EU
- Tuscany Health Ecosystem
- Advanced ERC
- Regione Toscana/Istituto per lo Studio, la Prevenzione e la Rete Oncologica
Zitieren
APA
Tatoni, D., Dalsass, M., Brunelli, G., Chiariello, M., Grandi, G., & D'Aurizio, R. (2025). Efficient and effective identification of cancer neoantigens from tumor only RNA-seq. NAR Genomics and Bioinformatics. https://doi.org/10.1093/nargab/lqaf026
Vancouver
Tatoni D, Dalsass M, Brunelli G, Chiariello M, Grandi G, D'Aurizio R. Efficient and effective identification of cancer neoantigens from tumor only RNA-seq. NAR Genomics and Bioinformatics. 2025. doi:10.1093/nargab/lqaf026
BibTeX
@article{Tatoni2025,
author = {Tatoni, Danilo and Dalsass, Mattia and Brunelli, Giulia and Chiariello, Mario and Grandi, Guido and D'Aurizio, Romina},
title = {Efficient and effective identification of cancer neoantigens from tumor only RNA-seq},
journal = {NAR Genomics and Bioinformatics},
year = {2025},
doi = {10.1093/nargab/lqaf026}
}
EUVIMED